A study from Emory University suggests that levodopa, a medication that increases dopamine levels in the brain, may help ...

A study from Emory University suggests that levodopa, a medication that increases dopamine levels in the brain, may help treat individuals with ...

Only 1 participant in each cohort reached the primary outcome, which was a 50% or greater improvement in BFMDR score. Levodopa did not show a significant benefit in reducing dystonia, disability, or ...

Despite being a mainstay of Parkinson's disease treatment, levodopa, a dopamine-replenishing medication, can cause nasty side ...

Despite past failures, Denali's extensive pipeline and solid financial runway make it a compelling buy at current low stock ...

Q4 2024 Earnings Conference Call March 20, 2025 8:30 AM ET. Company Participants. Samira Sakhia - President and Chief Executive Officer Arvi ...

左旋多巴，也称为L-DOPA，以多个品牌名称出售，是一种多巴胺能药物，用于治疗帕金森病和某些其他疾病，如多巴胺反应性肌 ...

Reports record-high revenues since inceptionMONTREAL, March 20, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a pan-American (ex-US) specialty ...

Further information Decision makers have concluded that the clear rationale to not evaluate this product is due to it being a change to the formulation of an existing product as per section 7.1.3 of ...

GOTHENBURG, SE / ACCESS Newswire / March 12, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, March 12, 2025 - ...

AbbVie has launched its Produodopa therapy for Parkinson’s disease onto the market in the EU, becoming the first and only 24-hour levodopa-based subcutaneous infusion therapy for the ...